Manufacturing and distributing effective vaccinations against COVID-19 has been heralded as the only way out of the pandemic and the race is on to get as many doses produced as possible. With demand through the roof, producing these life-saving drugs has become a lucrative business, and the global coronavirus vaccine market will reach an enormous value of $35 billion (£25.1bn) in 2021 and is expected to grow to $42 billion (£30.6bn) by 2022, according to Arizton. But who is that money going to? Click or scroll through to find out which companies are making billions from producing COVID-19 vaccines, ranked in order of the number of doses they are set to produce.